FYARRO
Live / Allowed — Publication / registration review complete (as of 18 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 Oct 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99464343
- Mark type
- Design + words
- Filed
- 27 Oct 2025
- Published for opposition
- 07 Apr 2026
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in oncology; Pharmaceutical preparations for the treatment of physiological diseases
Owner
- Aadi Bioscience, Inc., Morristown, NJ, US
Prosecution history
- 01 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Mar 2026 — EXAMINER'S AMENDMENT ENTERED
- 12 Mar 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 12 Mar 2026 — EXAMINERS AMENDMENT E-MAILED
- 12 Mar 2026 — EXAMINERS AMENDMENT -WRITTEN
- 11 Mar 2026 — ASSIGNED TO EXAMINER
- 07 Mar 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 08 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 27 Oct 2025 — NEW APPLICATION ENTERED